[1] |
Ding HX, Xu Q, Wang BG, et al. MetaDE-based analysis of circRNA expression profiles involved in gastric cancer[J]. Dig Dis Sci, 2020, 65: 2884-2895.
|
[2] |
Li XW, Yang WH, Xu J. Circular RNA in gastric cancer[J]. Chin Med J (Engl), 2020, 133: 1868-1877.
|
[3] |
Liu J, Li Z, Teng W, et al. Identification of downregulated circRNAs from tissue and plasma of patients with gastric cancer and construction of a circRNA-miRNA-mRNA network[J]. J Cell Biochem, 2020, 121: 4590-4600.
|
[4] |
冯天瑞, 严维刚. 环状RNAs在前列腺癌中的研究进展[J]. 基础医学与临床, 2022, 42: 179-183.
|
[5] |
Shao Y, Tao X, Lu R, et al. Hsa_circ_0065149 is an indicator for early gastric cancer screening and prognosis prediction[J]. Pathol Oncol Res, 2020, 26: 1475-1482.
|
[6] |
Han Z, Zhang Y, Sun Y, et al. ERβ-mediated alteration of circATP2B1 and miR-204-3p signaling promotes invasion of clear cell renal cell carcinoma[J]. Cancer Res, 2018, 78: 2550-2563.
|
[7] |
Wang F, Li X, Zhao X, et al. Detection of a 5-circRNA signature to improve prognostic prediction in gastric cancer[J]. J Investig Med, 2020, 68: 762-769.
|
[8] |
Wu J, Chen Z, Song Y, et al. CircRNA_0005075 suppresses carcinogenesis via regulating miR-431/p53/epithelial-mesenchymal transition axis in gastric cancer[J]. Cell Biochem Funct, 2020, 38: 932-942.
|
[9] |
Xia T, Pan Z, Zhang J. CircSMC3 regulates gastric cancer tumorigenesis by targeting miR-4720-3p/TJP1 axis[J]. Cancer Med, 2020, 9: 4299-4309.
|
[10] |
Yang W, Ju HY, Tian XF. Circular RNA-ABCB10 suppresses hepatocellular carcinoma progression through upregulating NRP1/ABL2 via sponging miR-340-5p/miR-452-5p[J]. Eur Rev Med Pharmacol Sci, 2020, 24: 2347-2357.
|
[11] |
Zhu L, Wang C, Lin S, et al. CircKIAA0907 retards cell growth, cell cycle, and autophagy of gastric cancer in vitro and inhibits tumorigenesis in vivo via the miR-452-5p/KAT6B axis[J]. Med Sci Monit, 2020, 26: e924160.doi: 10.12659/MSM.924160.
|
[12] |
Xin D, Xin Z. CircRNA_100782 promotes roliferation and metastasis of gastric cancer by downregulating tumor suppressor gene Rb by adsorbing miR-574-3p in a sponge form[J]. Eur Rev Med Pharmacol Sci, 2020, 24: 8845-8854.
|
[13] |
Wang C, Chen Q, Li S, et al. Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas[J]. Oncotarget, 2017, 8: 10287-10297.
|
[14] |
Izycka N, Sterzynska K, Januchowski R, et al. Sema-phorin 3A (SEMA3A), protocadherin 9 (PCdh9), and S100 calcium binding protein A3 (S100A3) as potential biomarkers of carcinogenesis and chemoresistance of different neoplasms, including ovarian cancer-review of literature[J]. Ginekol Pol, 2019, 90: 223-227.
|
[15] |
Chen Y, Xiang H, Zhang Y, et al. Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer[J]. Clin Exp Metastasis, 2015, 32: 417-428.
|